Patents Assigned to The United Stated of America, as represented by the Secretary, Department of Health & Human Services
  • Patent number: 9921211
    Abstract: Described herein are compositions, methods, a system, and kits for detection of endocrine disruptor chemicals (EDCs) in samples, such as samples of water including but not limited to waste water treatment plant effluent, using a live-cell fluorescence-based nuclear translocation reporter system. Upon binding of a ligand to a fluorescent-labeled reporter protein, the protein (and therefore the fluorescence) is translocated in a ligand level-dependent manner from the cytoplasm to the nucleus of live mammalian cells; this translocation is detectable as diffuse (cytoplasmic) fluorescence converting to localized, brightly fluorescent nuclei. The described kits can be used to reliably detect very low levels of EDC contamination, including in high throughput analysis systems as described.
    Type: Grant
    Filed: April 22, 2015
    Date of Patent: March 20, 2018
    Assignee: The United Stated of America, as Represented by The Secretary, Department of Health and Human Services
    Inventors: Gordon L. Hager, Diana A. Stavreva
  • Patent number: 9732337
    Abstract: The instant invention provides polyvalent RNA nanoparticles comprising RNA motifs as building blocks that can form RNA nanotubes. The polyvalent RNA nanoparticles are suitable for therapeutic or diagnostic use in a number of diseases or disorders.
    Type: Grant
    Filed: June 16, 2010
    Date of Patent: August 15, 2017
    Assignees: The United Stated of America, as represented by the Secretary, Department of Health & Human Services, The Regents of the University of California
    Inventors: Bruce A. Shapiro, Yaroslava G. Yingling, Eckart Bindewald, Wojciech Kasprzak, Luc Jaeger, Isil Severcan, Cody Geary, Kirill Afonin
  • Patent number: 9663812
    Abstract: A system is disclosed for thawing a frozen specimen that includes a cryovial containing a frozen specimen, a centrifuge tube containing a medium, and an adaptor for suspending the cryovial over the centrifuge tube in an inverted position, wherein the adaptor has an elongated tubular body defining opposed proximal and distal ends, and it has an axial bore extending from the distal end thereof to the proximal end thereof to define an outer periphery and an inner periphery, and wherein the outer periphery is dimensioned for insertion into the centrifuge tube and the inner periphery is dimensioned to receive the cryovial in an inverted position.
    Type: Grant
    Filed: March 18, 2015
    Date of Patent: May 30, 2017
    Assignee: The United Stated of America, as represented by the Secretary, Department of Health & Human Services
    Inventors: Mario Roederer, Margaret H. Beddall, Pratip K. Chattopadhyay
  • Patent number: 5171663
    Abstract: Monoclonal antibodies against complement regulatory protein sgp 120 are provided.
    Type: Grant
    Filed: June 14, 1989
    Date of Patent: December 15, 1992
    Assignee: The United Stated of America as represented by the Secretary of the Department of Health and Human Services
    Inventors: Milan Basta, Carl H. Hammer, Michael M. Frank